JCR Pharmaceuticals Co., Ltd.

Symbol: JCRRF

PNK

6.2

USD

Market price today

  • 18.8882

    P/E Ratio

  • -0.0016

    PEG Ratio

  • 773.77M

    MRK Cap

  • 0.00%

    DIV Yield

JCR Pharmaceuticals Co., Ltd. (JCRRF) Financial Statements

On the chart you can see the default numbers in dynamics for JCR Pharmaceuticals Co., Ltd. (JCRRF). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of JCR Pharmaceuticals Co., Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005

balance-sheet.row.cash-and-short-term-investments

0132783097726260
11193
8497
6112
5809.8
3875.6
4873.5
7244.3
4691.9
4067
4419
6235.9
5952.6
6985.4
4096
3126.8
3346.5

balance-sheet.row.short-term-investments

0-214244-225
220
661
1217
300.3
1927
3736
6196.8
3869.5
3201
2979.7
4333.9
3919.9
5925.5
3183.2
2468.2
2619

balance-sheet.row.net-receivables

011137155858183
7977
8835
7599
5824.9
5994.4
5621.1
4565.7
5449.1
4580.2
4407.6
3378.3
3000.5
2906.7
3033
4012.6
4139.8

balance-sheet.row.inventory

0185141463613554
8855
9117
9023
7737.7
7342.9
6401.5
5105.4
4990.2
5110.4
4574.8
4097.4
3214.5
3339.5
3667.1
3953.6
4606.2

balance-sheet.row.other-current-assets

04873990548
317
919
593
942.7
1153.4
294.9
457.4
854.6
485.3
419.3
1239.4
2067.3
1373.3
2452
556.8
506.8

balance-sheet.row.total-current-assets

0478026218848545
28342
27368
23327
20315.2
18366.2
17191
17372.8
15985.8
14242.8
13820.7
14951
14234.9
14605
13248.2
11649.8
12599.3

balance-sheet.row.property-plant-equipment-net

0326812678217172
14875
11061
10853
11387.7
11445
11611.9
11392.1
10367.1
9737.2
10319.2
8911.7
7435
6722
6665.2
6829.2
7135

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0365229603232
263
0
0
0
0
0
0
0
99.1
120.5
118.9
59.3
18.7
20
16.9
21.9

balance-sheet.row.goodwill-and-intangible-assets

0365229603232
263
110
112
67.6
84
75.2
94.6
78.8
99.1
120.5
118.9
59.3
18.7
20
16.9
21.9

balance-sheet.row.long-term-investments

0908119862797
2188
2280
1977
3287.2
2320.7
155.1
-2900.5
-335.9
49
1432.3
188.9
-1416.5
-4203.8
-17.8
-859.7
-1567.2

balance-sheet.row.tax-assets

0135724331739
721
378
1485
576.6
2207.9
4093.7
6365.6
3869.5
3201
2979.7
4333.9
3919.9
5925.5
3183.2
24.5
274.2

balance-sheet.row.other-non-current-assets

0362783296
1383
1317
643
1327.3
3130.9
5052.7
7505.3
5191.2
4839.2
4124.7
4977.8
4454.4
7076.8
4487.1
3138.2
3336

balance-sheet.row.total-non-current-assets

0471333494425236
19430
15146
15070
16069.9
16980.6
16895
16091.5
15301.2
14724.5
15996.8
14197.2
10532.3
9613.8
11154.6
9149.1
9199.9

balance-sheet.row.other-assets

0223
3
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0949379713473784
47775
42516
38398
36385
35346.8
34086.1
33464.3
31287
28967.3
29817.5
29148.2
24767.2
24218.8
24402.8
20798.9
21799.2

balance-sheet.row.account-payables

0156313242932
679
586
585
700.3
783.4
534
697.1
735.6
229.4
955.2
914.9
808.9
438.3
345.4
331.9
382.6

balance-sheet.row.short-term-debt

0173001515012850
4926
3808
3086
1723.8
1985.4
2158.2
2101.4
2278.1
2238.7
2025.5
1994.5
1893.2
1877.2
2282.9
2404
2909.6

balance-sheet.row.tax-payables

03359152646
534
801
887
69.6
764.2
76.9
501.7
308.8
138.4
323.9
553.2
0
0
0
48.4
28.4

balance-sheet.row.long-term-debt-total

0550029505250
3831
1923
2718
3115.1
1208.3
1479.8
2158.1
1874.4
1801.2
2067
3163.1
3190.4
3199.2
2900.5
1844.1
3537.9

Deferred Revenue Non Current

0-428-343-378
-343
-440
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

012975134729687
651
2746
1907
2282.9
3298.3
2442.8
2865.5
2612.2
1952.8
1852.2
2452.8
1791.5
1747.7
1415
655.2
672.2

balance-sheet.row.total-non-current-liabilities

0676339946203
4763
2961
3766
4092.2
2217
2686.2
3219.6
2164.4
1913.3
2152.4
3302.3
3288.8
3303.4
3108.9
1931.8
3602.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0734442
77
251
411
632.1
786.6
971.5
1127.7
1280.1
1534.6
1713.2
739.9
704.4
0
0
0
0

balance-sheet.row.total-liab

0425254604835231
15197
11645
10871
8799.2
8284.1
7821.2
8883.5
7790.4
6334.2
6985.4
8664.4
7782.5
7366.7
7152.2
5322.9
7567.3

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0906190619061
9061
9061
9061
9061.9
9061.9
9061.9
9061.9
9061.9
9061.9
9061.9
8061.9
7504.9
7504.9
7504.9
5554.9
5171.2

balance-sheet.row.retained-earnings

0342733324120904
15039
13350
10469
8149.3
6930.1
5780.5
4445.3
3562
3211.9
2964.6
2523.8
1474.1
1204.4
1077.1
3105
3390

balance-sheet.row.accumulated-other-comprehensive-income-loss

0142111841159
1262
1286
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0740673957255
7027
6985
7812
10373.9
11070
11421.9
11073.1
10872.2
10359
10805.4
9897.9
8001
8131
8659.4
6804.8
5665.9

balance-sheet.row.total-stockholders-equity

0521615088138379
32389
30682
27342
27585
27062
26264.3
24580.2
23496.1
22632.8
22831.8
20483.5
16979.9
16840.3
17241.4
15464.7
14227.1

balance-sheet.row.total-liabilities-and-stockholders-equity

0949379713473784
47775
42516
38398
36385
35346.8
34086.1
33464.3
31287
28967.3
29817.5
29148.2
24767.2
24218.8
24402.8
20798.9
21799.2

balance-sheet.row.minority-interest

0251205174
189
189
185
0.9
0.8
0.6
0.6
0.5
0.3
0.3
0.2
4.8
11.8
9.2
11.3
4.8

balance-sheet.row.total-equity

0524125108638553
32578
30871
27527
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0886722302572
2408
2941
3194
3587.6
4247.6
3891.1
3296.3
3533.6
3250
4412
4522.8
2503.4
1721.8
3165.4
1608.5
1051.8

balance-sheet.row.total-debt

0228001810018100
8757
5731
5804
4838.9
3193.7
3638
4259.5
4152.5
4039.8
4092.4
5157.5
5083.6
5076.4
5183.4
4248.1
6447.5

balance-sheet.row.net-debt

09522-12633-8160
-2216
-2105
909
-670.6
1245.1
2500.5
3212
3330.1
3173.9
2653.2
3255.5
3050.8
4016.5
4270.6
3589.5
5720

Cash Flow Statement

The financial landscape of JCR Pharmaceuticals Co., Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005

cash-flows.row.net-income

05412194048653
3422
4928
3895
2492.8
2459.3
2334.3
1677.5
1064.8
942.1
1274.1
1583.9
562.1
436.9
-611.8
39.2
-1927.8

cash-flows.row.depreciation-and-amortization

0199719451892
1434
1343
1382
1447.5
1407.7
1352.4
1112
979.2
1101.4
975.7
743.3
694.8
575.9
586
620.5
548.3

cash-flows.row.deferred-income-tax

0-9221-3074-983
-1291
-1310
-145
-1257
-392.8
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0173177149
175
144
77
79.4
85.6
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-2956-9030323
1398
-1585
-2391
-208.2
-1631.4
-2178.5
2298.8
-342.7
-2427.9
-1588.8
-619.2
254
627
814.1
759.9
1412.7

cash-flows.row.account-receivables

03269-7501-204
892
-1639
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-3877-1082-4699
258
-157
-1314
-402.9
-947
-1292.5
-138.8
95.7
-583.9
-574.4
-953.6
112.5
320.1
294.3
650.5
2186.4

cash-flows.row.account-payables

0238-16082253
92
1639
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-258611612973
156
-1428
-1077
194.7
-684.3
-886
2437.6
-438.4
-1843.9
-1014.3
334.3
141.5
306.9
519.8
109.4
-773.6

cash-flows.row.other-non-cash-items

0-905-133307
-211
385
315
-1160.1
-119.4
-1009.1
-522.9
-39.9
-36.7
-679.3
649.5
314.7
283.7
341.1
-673
608.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-8560-11333-7527
-4838
-895
-999
-1550.6
-1413.9
-1340.3
-2409.6
-1048
-292.1
-1152.2
-1922.6
-847.1
-2091.6
-2152.4
-166.3
-976

cash-flows.row.acquisitions-net

0-67178167-2747
0
0
-11
0
0
-62.7
64.6
0
0
9.6
-6.9
-8.9
901
-1177.2
0
0

cash-flows.row.purchases-of-investments

0-906-300-391
-30
-100
-1105
-42.8
-724.4
-2040.6
-1071.9
-308.3
-528.5
-1326.2
-3231.3
-2095.4
-1749.8
-4415.7
-52.4
-143.4

cash-flows.row.sales-maturities-of-investments

0259300584
798
1257
450
736.3
1182.9
1957.6
750.2
1150.5
1906.8
421.9
1429.6
2700
1100
1177.7
397.5
0

cash-flows.row.other-investing-activites

0922-846791
-91
-22
78
15.6
-25.2
-59.1
63
27.3
453.4
-155.2
334.4
49.3
823.8
-1221.3
-45.7
-114.3

cash-flows.row.net-cash-used-for-investing-activites

0-15002-3250-3290
-4161
240
-1587
-841.4
-980.6
-1419.7
-2668.3
-178.5
1539.7
-2211.8
-3396.7
121.8
-571.5
-4634.5
133.1
-1233.7

cash-flows.row.debt-repayment

0-3050-750-650
-850
-413
-233
-550.3
-759.5
-665.3
-580.6
-430.8
-468
-666.4
-731.6
-367.2
-985.8
-485.4
-817.2
-1899.7

cash-flows.row.common-stock-issued

0101013
15
26
0
0
0
0
0
0
0
0
2256.5
0
0
3875.6
0
0

cash-flows.row.common-stock-repurchased

0-10-10-13
-15
-26
0
0
0
0
0
0
0
0
537.7
0
0
1409.6
0
0

cash-flows.row.dividends-paid

0-2739-2169-1083
-989
-834
-748
-699.3
-640
-592.4
-412.5
-382.2
-385.8
-485.6
-253.2
-270.2
-273.3
-268.1
-242.1
-234

cash-flows.row.other-financing-activites

0773774010037
3887
330
-1194
1395.9
85.5
-3.7
623.7
574.9
-211.5
-124.5
484.7
-638.8
746.9
1409
-48.5
3814.4

cash-flows.row.net-cash-used-provided-by-financing-activities

01948-21798304
2048
-917
-2175
146.3
-1314
-1261.4
-369.4
-238.1
-1065.3
-1276.5
1756.4
-1276.2
-512.2
4531.2
-1107.8
1680.6

cash-flows.row.effect-of-forex-changes-on-cash

01099612-22
20
12
14
-15
-27.1
44.3
104.4
39
-0.3
-15.6
-3.3
-35.4
-16.3
10.9
16
4.8

cash-flows.row.net-change-in-cash

0-17455447315332
2837
3241
-614
1941.2
-120
-2137.7
1632.1
1283.8
53
-3522.3
713.9
635.7
823.5
1037
-212.1
1093

cash-flows.row.cash-at-end-of-period

0132783073326260
10928
8091
4850
5464.5
3523.3
3643.3
5781
4148.9
2865.1
2812.1
6334.4
5620.5
4984.8
4161.3
3124.3
3336.4

cash-flows.row.cash-at-beginning-of-period

0307332626010928
8091
4850
5464
3523.3
3643.3
5781
4148.9
2865.1
2812.1
6334.4
5620.5
4984.8
4161.3
3124.3
3336.4
2243.4

cash-flows.row.operating-cash-flow

0-5500928910341
4927
3905
3133
2651.3
2201.7
499.1
4565.4
1661.4
-421.1
-18.3
2357.5
1825.6
1923.5
1129.5
746.6
641.3

cash-flows.row.capital-expenditure

0-8560-11333-7527
-4838
-895
-999
-1550.6
-1413.9
-1340.3
-2409.6
-1048
-292.1
-1152.2
-1922.6
-847.1
-2091.6
-2152.4
-166.3
-976

cash-flows.row.free-cash-flow

0-14060-20442814
89
3010
2134
1100.7
787.8
-841.2
2155.8
613.4
-713.2
-1170.6
434.9
978.4
-168
-1022.9
580.3
-334.6

Income Statement Row

JCR Pharmaceuticals Co., Ltd.'s revenue saw a change of NaN% compared with the previous period. The gross profit of JCRRF is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005

income-statement-row.row.total-revenue

0343435108230085
24781
23160
20594
18085
17438.4
16855.7
15705.9
14099.9
12845.1
14457.8
14387.4
12082.7
11871.9
8544.7
7648.8
8099.7

income-statement-row.row.cost-of-revenue

08886104617812
7901
6567
6128
5731.7
6459.4
5740.9
5842.1
5036.9
4213
5227.3
4142.5
3555.7
3824.7
2818.3
2881.4
3653.6

income-statement-row.row.gross-profit

0254574062122273
16880
16593
14466
12353.3
10979
11114.7
9863.8
9063
8632
9230.5
10244.9
8527
8047.2
5726.4
4767.4
4446.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0583861
4
16
10
51.7
107
109.7
26.2
22.7
24.8
16.1
128.1
121.7
248.7
-287.9
-199.1
-2331.4

income-statement-row.row.operating-expenses

0204802068614003
13635
11625
10681
9991.3
8826.2
9100.1
8318.4
7912.1
7542.3
7822.9
8237.3
7980.5
7765.2
5890
4802.8
3986.6

income-statement-row.row.cost-and-expenses

0293663114721815
21536
18192
16809
15723
15285.6
14841.1
14160.4
12949
11755.3
13050.3
12379.8
11536.2
11589.9
8708.3
7684.2
7640.2

income-statement-row.row.interest-income

03377
19
20
20
16.6
27.1
31.1
34.4
36.4
50.2
56.7
47.1
58.4
52.6
45.8
4
3.8

income-statement-row.row.interest-expense

0444542
22
21
27
29
32.7
38.1
43.5
50.3
57.5
59
69
63
65.2
58.7
51.6
49.6

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0437-529384
178
-39
111
130.8
306.5
319.7
132
-86.1
-120.9
-97.3
-346.3
-142.5
-146.3
-184.4
284
-62.9

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0583861
4
16
10
51.7
107
109.7
26.2
22.7
24.8
16.1
128.1
121.7
248.7
-287.9
-199.1
-2331.4

income-statement-row.row.total-operating-expenses

0437-529384
178
-39
111
130.8
306.5
319.7
132
-86.1
-120.9
-97.3
-346.3
-142.5
-146.3
-184.4
284
-62.9

income-statement-row.row.interest-expense

0444542
22
21
27
29
32.7
38.1
43.5
50.3
57.5
59
69
63
65.2
58.7
51.6
49.6

income-statement-row.row.depreciation-and-amortization

0199719451892
1434
1343
1382
1447.5
1407.7
1352.4
1112
979.2
1101.4
975.7
743.3
694.8
575.9
586
620.5
548.3

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

04975199338269
3244
4967
3784
2362
2152.8
2014.6
1545.5
1150.9
1063
1371.4
1930.3
704.6
583.2
-427.4
-244.8
-1864.8

income-statement-row.row.income-before-tax

05412194048653
3422
4928
3895
2492.8
2459.3
2334.3
1677.5
1064.8
942.1
1274.1
1583.9
562.1
436.9
-611.8
39.2
-1927.8

income-statement-row.row.income-tax-expense

0162548861764
742
1217
825
629.5
669.7
651.9
381.1
334
308
347.5
279.8
21.2
34.4
1139.6
69
-659

income-statement-row.row.net-income

03772145076892
2678
3715
3070
1863.2
1789.5
1682.4
1296.2
730.7
634
926.5
1302.9
539.9
400
-1751.1
-31.9
-1272.4

Frequently Asked Question

What is JCR Pharmaceuticals Co., Ltd. (JCRRF) total assets?

JCR Pharmaceuticals Co., Ltd. (JCRRF) total assets is 94937000000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.748.

What is company free cash flow?

The free cash flow is 45.128.

What is enterprise net profit margin?

The net profit margin is 0.130.

What is firm total revenue?

The total revenue is 0.189.

What is JCR Pharmaceuticals Co., Ltd. (JCRRF) net profit (net income)?

The net profit (net income) is 3772000000.000.

What is firm total debt?

The total debt is 22800000000.000.

What is operating expences number?

The operating expences are 20480000000.000.

What is company cash figure?

Enretprise cash is 0.000.